Intended for healthcare professionals

Editorials

Sulfonylureas as second line treatment for type 2 diabetes

BMJ 2018; 362 doi: https://doi.org/10.1136/bmj.k3041 (Published 18 July 2018) Cite this as: BMJ 2018;362:k3041